Role of Oxidative Stress and Antioxidants in Neurodegenerative Diseases
暂无分享,去创建一个
[1] R. Zollinger,et al. Mechanisms of oxygen free radical-induced calcium overload in endothelial cells. , 1990, Surgery.
[2] Allen D. Roses,et al. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease , 1997, Neurogenetics.
[3] R. Weizman,et al. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study. , 2001, Archives of general psychiatry.
[4] B. Ames,et al. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. , 1991, The Biochemical journal.
[5] D. Commenges,et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.
[6] Robert H. Brown,et al. Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis , 1997, Annals of neurology.
[7] B. Rosen,et al. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10 , 1997, Annals of neurology.
[8] R. Orrell,et al. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. , 1995, Journal of medical genetics.
[9] J. Julien,et al. Transgenic Mice in the Study of ALS: The Role of Neurofilaments , 1998, Brain pathology.
[10] K. Nakashima,et al. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1: gene multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. , 1996, Journal of neuropathology and experimental neurology.
[11] A. Schatzberg,et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. , 1997, JAMA.
[12] M. Gurney,et al. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis , 1998, Annals of neurology.
[13] W. Markesbery,et al. Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.
[14] M. Weiner,et al. ANTIOXIDANT ENZYMES IN ALZHEIMER'S DISEASE , 1988 .
[15] J. Knittweis,et al. The effect of apoE on dementia is not through atherosclerosis: the Rotterdam study. , 2000, Neurology.
[16] J. Growdon,et al. Treatment for Alzheimer's disease? , 1992, The New England journal of medicine.
[17] Z. Rossetti,et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. , 1988, Biochemical pharmacology.
[18] P. Crino,et al. Involvement of free radicals in dementia of the Alzheimer type: A hypothesis , 1990, Neurobiology of Aging.
[19] D. Borchelt,et al. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.
[20] A D Roses,et al. Apolipoprotein E-epsilon 2 and Alzheimer's disease , 1997, Neurology.
[21] A. Bush,et al. Metals and neuroscience. , 2000, Current opinion in chemical biology.
[22] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] N. Robakis,et al. Immunohistochemical evidence of antioxidant stress in Alzheimer's disease , 1992 .
[24] E. Hirsch,et al. Glutathione peroxidase, glial cells and Parkinson's disease , 1993, Neuroscience.
[25] M. Rao,et al. Nitric Oxide Scavenging by Curcuminoids , 1997, The Journal of pharmacy and pharmacology.
[26] A. Hofman,et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.
[27] C. Masters,et al. Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein , 2002, The Journal of Neuroscience.
[28] L. Packer,et al. Antioxidants and herbal extracts protect HT-4 neuronal cells against glutamate-induced cytotoxicity , 2000, Free radical research.
[29] R. Orrell. Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations , 2000, Neuromuscular Disorders.
[30] M. Beal,et al. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.
[31] T. Perry,et al. What excitotoxin kills striatal neurons in Huntington's disease? Clues from neurochemical studies , 1990, Neurology.
[32] M. Beal. Mitochondria, free radicals, and neurodegeneration , 1996, Current Opinion in Neurobiology.
[33] S. Schwartz,et al. Lycopene : Chemical and Biological Properties , 1999 .
[34] P. Ince,et al. Oxidative damage to protein in sporadic motor neuron disease spinal cord , 1995, Annals of neurology.
[35] W. D. Ehmann,et al. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.
[36] D. Dickson,et al. Oxidative protein damage in cells engaged in &bgr;-amyloidosis is related to apoE genotype , 2002, Neuroreport.
[37] B. Sommer,et al. Neuron loss in APP transgenic mice , 1998, Nature.
[38] M. Karas,et al. Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. , 1999, Nutrition and cancer.
[39] P. Bossuyt,et al. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. , 1995, Archives of neurology.
[40] S H Appel,et al. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. , 1995, Brain : a journal of neurology.
[41] A. Henriques,et al. The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats , 2001, Phytotherapy research : PTR.
[42] M. Beal,et al. Increased oxidative damage to DNA in ALS patients. , 2000, Free radical biology & medicine.
[43] C. Marsden,et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study , 1994, Movement disorders : official journal of the Movement Disorder Society.
[44] P. Di Mascio,et al. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. , 1989, Archives of biochemistry and biophysics.
[45] Satoshi Takahashi,et al. Concentrations of α-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia , 1994, Neuroscience Letters.
[46] M. Hayden,et al. Positron emission tomography in the early diagnosis of Huntington's disease , 1986, Neurology.
[47] A. Lavy,et al. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. , 1995, The American journal of clinical nutrition.
[48] G. Omenn,et al. Strategy and planning for chemopreventive drug development: Clinical development plans II , 1996, Journal of cellular biochemistry. Supplement.
[49] V. Meininger,et al. Genetics of familial ALS and consequences for diagnosis 1 , 1999, Journal of the Neurological Sciences.
[50] B. Halliwell,et al. Action of lead(II) and aluminium (III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. , 1988, Biochimica et biophysica acta.
[51] W. Robberecht,et al. Rapid Communication: Cu/Zn Superoxide Dismutase Activity in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1994, Journal of neurochemistry.
[52] G. Cohen. Monoamine oxidase, hydrogen peroxide, and Parkinson's disease. , 1987, Advances in neurology.
[53] G. Cole,et al. Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .
[54] J. Olney. Excitatory amino acids and neuropsychiatrie disorders , 1989, Biological Psychiatry.
[55] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[56] Robert H. Brown,et al. Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis , 1993, Journal of neurochemistry.
[57] W. Snider,et al. Motor neuron growth factors , 1996, Neurology.
[58] R. Tanzi,et al. Role of free radicals and metal ions in the pathogenesis of Alzheimer's disease. , 1999, Metal ions in biological systems.
[59] P Woodbury,et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.
[60] S. Clinton,et al. Lycopene: chemistry, biology, and implications for human health and disease. , 2009, Nutrition reviews.
[61] F. Zemlan,et al. Superoxide dismutase, chromosome 21, and Alzheimer's disease , 1986, Biological Psychiatry.
[62] S. Fahn. An open trial of high-dosage antioxidants in early Parkinson's disease. , 1991, The American journal of clinical nutrition.
[63] E. Corder,et al. Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer’s disease , 1999, Cellular and Molecular Life Sciences CMLS.
[64] S. Kish,et al. Glutathione peroxidase activity in Parkinson's disease brain , 1985, Neuroscience Letters.
[65] M. Katan,et al. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. , 1996, The American journal of clinical nutrition.
[66] M. Raskind,et al. Iron pigment in the brain of a man with tardive dyskinesia. , 1985, The American journal of psychiatry.
[67] G. Krishna,et al. Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion (MPP+): reductive activation by NADPH cytochrome P-450 reductase. , 1986, Biochemical and biophysical research communications.
[68] D. Jeste,et al. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia , 1990, Biological Psychiatry.
[69] J. Lieberman,et al. Diabetes and development of tardive dyskinesia. , 1993, The American journal of psychiatry.
[70] N. Hattori,et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[71] L. Ang,et al. Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro , 1990, Journal of neurochemistry.
[72] C. Link,et al. In vivo aggregation of beta-amyloid peptide variants. , 1998, Journal of neurochemistry.
[73] M. Mattson,et al. Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis , 1998, Annals of neurology.
[74] P. Fuchs,et al. Myricetin and quercetin, the flavonoid constituents ofGinkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca2+-loaded brain neurons , 1994, Brain Research.
[75] Y. Christen,et al. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid , 2000 .
[76] S. Moncada,et al. Inhibition of nitric oxide synthase as a potential therapeutic target. , 1999, Annual review of pharmacology and toxicology.
[77] D. L. Morris,et al. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. , 1994, JAMA.
[78] J. Taljaard,et al. Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? , 1995, Medical hypotheses.
[79] C. Masters,et al. The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.
[80] M. Tabaton,et al. Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.
[81] M. Beal,et al. Elevated “Hydroxyl Radical” Generation In Vivo in an Animal Model of Amyotrophic Lateral Sclerosis , 1998, Journal of neurochemistry.
[82] V. Menon,et al. Neuroprotective role of curcumin from Curcuma longa on ethanol‐induced brain damage , 1999, Phytotherapy research : PTR.
[83] Pascale Barberger-Gateau,et al. Relationships between Cholesterol, Apolipoprotein E Polymorphism and Dementia: A Cross-Sectional Analysis from the PAQUID Study , 2000, Neuroepidemiology.
[84] W. Glazer,et al. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. , 1993, Archives of general psychiatry.
[85] D. Horrobin,et al. Essential fatty acids in plasma phospholipids in schizophrenics , 1989, Biological Psychiatry.
[86] E. Otomo,et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.
[87] M. Dichter,et al. Antioxidant therapy in neurologic disease. , 2001, Archives of neurology.
[88] E. Land,et al. Chemically induced Parkinson's disease: intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion. , 1987, Biochemical and biophysical research communications.
[89] P. Bickford,et al. Long-Term Dietary Strawberry, Spinach, or Vitamin E Supplementation Retards the Onset of Age-Related Neuronal Signal-Transduction and Cognitive Behavioral Deficits , 1998, The Journal of Neuroscience.
[90] G. Cole,et al. Vitamin E protects nerve cells from amyloid beta protein toxicity. , 1992, Biochemical and biophysical research communications.
[91] C A Ross,et al. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[92] A. Rao,et al. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study , 1998, Lipids.
[93] E. Parks,et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.
[94] G. Siest,et al. Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. , 1990, Gerontology.
[95] P J Whitehouse,et al. Evaluation of dementia. , 1996, The New England journal of medicine.
[96] J. Joseph. The putative role of free radicals in the loss of neuronal functioning in senescence , 1992, Integrative physiological and behavioral science : the official journal of the Pavlovian Society.
[97] F. Fazekas,et al. Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study , 1997, Journal of the Neurological Sciences.
[98] L. Beckett,et al. Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.
[99] O. Andreassen,et al. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis , 2000, Annals of neurology.
[100] W. Stahl,et al. Lycopene: a biologically important carotenoid for humans? , 1996, Archives of biochemistry and biophysics.
[101] A. Hofman,et al. Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.
[102] R. Schmidt,et al. Plasma Antioxidants and Cognitive Performance in Middle‐Aged and Older Adults: Results of the Austrian Stroke Prevention Study , 1998, Journal of the American Geriatrics Society.
[103] R. Schwarcz,et al. 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[104] V. O. Mora-Arellano,et al. Free radicals and singlet oxygen scavengers: reaction of a peroxy-radical with beta-carotene, diphenyl furan and 1,4-diazobicyclo (2,2,2)-octane. , 1981, Biochemical and biophysical research communications.
[105] J. Olney. Excitatory amino acids and neuropsychiatric disorders. , 1989, Biological psychiatry.
[106] V. Culotta,et al. Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[107] J. Kleijnen,et al. Ginkgo biloba for cerebral insufficiency. , 1992, British journal of clinical pharmacology.
[108] S. Azen,et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. , 1995, JAMA.
[109] Albert Hofman,et al. Cognitive Correlates of Ventricular Enlargement and Cerebral White Matter Lesions on Magnetic Resonance Imaging: The Rotterdam Study , 1994, Stroke.
[110] W. Pryor,et al. Noninvasive measures of oxidative stress status in humans. , 1991, Free radical biology & medicine.
[111] P. Bossuyt,et al. Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants , 1996, Journal of the Neurological Sciences.
[112] M. Karas,et al. Lycopene Interferes With Cell Cycle Progression and Insulin-Like Growth Factor I Signaling in Mammary Cancer Cells , 2000, Nutrition and cancer.
[113] L. Ganzini,et al. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. , 1991, Archives of general psychiatry.
[114] Kenneth Rockwood,et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. , 2002, Archives of neurology.
[115] R. Martins,et al. Increased Cerebral Glucose‐6‐Phosphate Dehydrogenase Activity in Alzheimer's Disease May Reflect Oxidative Stress , 1986, Journal of neurochemistry.
[116] M. Gurney,et al. Disease mechanisms revealed by transcription profiling in SOD1‐G93A transgenic mouse spinal cord , 2001, Annals of neurology.
[117] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[118] E. Stadtman,et al. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[119] A. Elkashef,et al. Vitamin E in the treatment of tardive dyskinesia. , 1990, The American journal of psychiatry.
[120] D. Selkoe,et al. Alzheimer's Disease--Genotypes, Phenotype, and Treatments , 1997, Science.
[121] T. Dawson,et al. Nitric oxide neurotoxicity , 1996, Journal of Chemical Neuroanatomy.
[122] D. Mckenna,et al. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. , 2001, Alternative therapies in health and medicine.
[123] A. Alavi,et al. Positron emission tomography imaging of regional cerebral glucose metabolism. , 1986, Seminars in nuclear medicine.
[124] J. Rothstein,et al. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[125] M. Shelanski,et al. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[126] C. Link,et al. In Vivo Aggregation of β‐Amyloid Peptide Variants , 1998 .
[127] R. Carraway,et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons , 1995, Neuron.
[128] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[129] B. Halliwell. Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? , 1989, Acta neurologica Scandinavica. Supplementum.
[130] Robert H. Brown,et al. Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis , 1997, Journal of neurochemistry.
[131] D. Gozal,et al. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1‐mediated motor neuron cell death and increase amyotrophic lateral sclerosis‐like transgenic mouse survival , 2002, Journal of neurochemistry.
[132] R N Kalaria,et al. Overlap between pathology of Alzheimer disease and vascular dementia. , 1999, Alzheimer disease and associated disorders.
[133] P. Jenner. Oxidative damage in neurodegenerative disease , 1994, The Lancet.
[134] I. Young,et al. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. , 1999, QJM : monthly journal of the Association of Physicians.
[135] M. V. Van Woert,et al. Brain peroxidase and catalase in Parkinson disease. , 1975, Archives of neurology.
[136] D. B. Williams,et al. Motor neuron disease (amyotrophic lateral sclerosis). , 1991, Mayo Clinic proceedings.
[137] B. Rosen,et al. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate , 1994, Annals of neurology.
[138] Robert H. Brown,et al. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice , 1995, Cell.
[139] M. Gearing,et al. Abeta-peptide length and apolipoprotein E genotype in Alzheimer's disease. , 1996, Annals of Neurology.
[140] R. Stewart,et al. Vascular Risk Factors and Alzheimer's Disease , 1999, The Australian and New Zealand journal of psychiatry.
[141] J. Greenamyre. The role of glutamate in neurotransmission and in neurologic disease. , 1986, Archives of neurology.
[142] R. Prior,et al. Antioxidant Capacity of Tea and Common Vegetables , 1996 .
[143] M. Longnecker,et al. Dietary Intake of Calcium, Magnesium and Antioxidants in Relation to Risk of Amyotrophic Lateral Sclerosis , 2000, Neuroepidemiology.
[144] T. Sarna,et al. Modulation by neuromelanin of the availability and reactivity of metal ions , 1992, Annals of neurology.
[145] Kohan,et al. Peripheral markers of oxidative stress in probable Alzheimer patients , 1999, European journal of clinical investigation.
[146] D. Snowdon,et al. Antioxidants and reduced functional capacity in the elderly: findings from the Nun Study. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.
[147] P. Murphy,et al. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. , 1994, The Journal of nutrition.
[148] B. Halliwell,et al. Oxygen radicals and the nervous system , 1985, Trends in Neurosciences.
[149] K. Wesnes,et al. A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment. , 1991, Current medical research and opinion.
[150] C. Behl,et al. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[151] R. Pamphlett. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS , 2000, Neurology.
[152] J. Haines,et al. A DNA segment encoding two genes very tightly linked to Huntington's disease. , 1987, Science.
[153] A. Campbell. The potential role of aluminium in Alzheimer's disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[154] J. Warter,et al. Prevention of mutant SOD1 motoneuron degeneration by copper chelators in vitro. , 2000, Journal of neurobiology.
[155] M. Banerjee,et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[156] P. Hollman,et al. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. , 1996, Free radical biology & medicine.
[157] J. Langston,et al. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.
[158] Y. Kagawa,et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.
[159] R. Gryglewski,et al. Flavonoids are scavengers of superoxide anions. , 1988, Biochemical pharmacology.
[160] Xudong Huang,et al. Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.
[161] J. Joseph,et al. A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.
[162] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[163] S. Fahn,et al. Alpha tocopherol in CSF of subjects taking high‐dose vitamin E in the DATATOP study , 1998, Neurology.
[164] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.
[165] C. Marsden,et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia , 1994, Annals of neurology.
[166] L. Balázs,et al. Evidence of an oxidative challenge in the Alzheimer's brain , 1994, Neurochemical Research.
[167] M. Gurney,et al. Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD , 1998, Acta Neuropathologica.
[168] H. Stähelin,et al. The Relation Between Antioxidants and Memory Performance in the Old and Very Old , 1997, Journal of the American Geriatrics Society.
[169] A. Algra,et al. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature , 2000, Journal of Neurology.
[170] T. Dawson,et al. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[171] P. Andersen,et al. [Familial amyotrophic lateral sclerosis]. , 1996, Duodecim; laaketieteellinen aikakauskirja.
[172] C. Masters,et al. The βA4 amyloid precursor protein binding to copper , 1994 .
[173] Cell Death and Diseases of the Nervous System , 1999 .
[174] R. Floyd. Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[175] Barbara Shukitt-Hale,et al. Reversals of Age-Related Declines in Neuronal Signal Transduction, Cognitive, and Motor Behavioral Deficits with Blueberry, Spinach, or Strawberry Dietary Supplementation , 1999, The Journal of Neuroscience.
[176] E. Rimm,et al. Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.
[177] A. Hofman,et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. , 1997, Archives of neurology.
[178] W. D. Ehmann,et al. Brain trace elements in Alzheimer's disease. , 1986, Neurotoxicology.
[179] K. Ingold,et al. beta-Carotene: an unusual type of lipid antioxidant. , 1984, Science.
[180] R. Prior,et al. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. , 1998, Clinical chemistry.
[181] J. Cumings,et al. Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication. , 1968, Journal of the neurological sciences.
[182] H. Vanderstichele,et al. Association of CSF apolipoprotein E, Aβ42 and cognition in Alzheimer’s disease , 2002, Neurobiology of Aging.
[183] G. Rouleau,et al. The Cu/Zn superoxide dismutase gene in ALS and parkinsonism-dementia of Guam. , 1994, NeuroReport.
[184] Turan M. Itil,et al. A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia , 1997 .
[185] T. Kamei,et al. Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex , 1997, Acta Neuropathologica.
[186] C. Behl,et al. Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins. , 2000, European journal of biochemistry.
[187] G. Annéren,et al. Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type , 1986, Acta neurologica Scandinavica.
[188] E. Stefani,et al. Evidence for autoimmunity in amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[189] G. M. Cole,et al. Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology , 2001, Neurobiology of Aging.
[190] B. Shukitt-Hale,et al. Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention , 2000, Mechanisms of Ageing and Development.
[191] C. Cross,et al. Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.
[192] C. Olanow,et al. Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.
[193] D. Jeste,et al. Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. , 1988, Schizophrenia bulletin.
[194] N. Inestrosa,et al. Cysteine 144 Is a Key Residue in the Copper Reduction by the β‐Amyloid Precursor Protein , 1999, Journal of neurochemistry.
[195] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[196] Mark A. Smith,et al. In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.
[197] I. Shoulson,et al. A prospective evaluation of cognitive decline in early Huntington's disease , 1995, Neurology.
[198] G. Britton,et al. Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. , 1997, Biochimica et biophysica acta.
[199] R. Hichwa,et al. PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline , 1986, Annals of neurology.
[200] J. Coyle,et al. Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.
[201] R. Floyd,et al. Peroxidation induced changes in synaptosomal transport of dopamine and γ-aminobutyric acid , 1989 .
[202] H. Feldman,et al. Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease , 1996, Nature Medicine.
[203] L. Packer. Oxidative stress, antioxidants, aging and disease , 1995 .
[204] S. Maxwell,et al. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia , 1998, International journal of geriatric psychiatry.
[205] C. Marsden,et al. Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.
[206] C. Masters,et al. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein , 1999, Nature Structural Biology.
[207] D. Butterfield,et al. In Vitro and in vivo Protein Oxidation Induced by Alzheimer's Disease Amyloid β‐Peptide (1–42) , 1999, Annals of the New York Academy of Sciences.
[208] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[209] Solomon H. Snyder,et al. Nitric oxide, a novel neuronal messenger , 1992, Neuron.
[210] R. Petersen,et al. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.
[211] F. Zemlan,et al. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation , 1989, Brain Research.
[212] D. Price,et al. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. , 1995, The American journal of pathology.
[213] M. Naoi,et al. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins. , 1993, Advances in neurology.
[214] P Riederer,et al. Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. , 1995, Arzneimittel-Forschung.
[215] J. Kaye,et al. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. , 1998, Archives of neurology.
[216] M. Gearing,et al. Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease , 1996 .
[217] A. Plaitakis,et al. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis , 1988, Annals of neurology.
[218] S. Agarwal,et al. Carotenoids and Chronic Diseases , 2000, Drug metabolism and drug interactions.
[219] Y. Oyama,et al. Ca(2+)-induced increase in oxidative metabolism of dissociated mammalian brain neurons: effect of extract of ginkgo biloba leaves. , 1993, Japanese journal of pharmacology.
[220] Klaus P. Ebmeier,et al. The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression , 1991, Acta psychiatrica Scandinavica.
[221] T. P. Krishnakantha,et al. Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats , 1997, Molecular and Cellular Biochemistry.
[222] M. Gurney,et al. Increased 3‐nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation , 1997, Annals of neurology.
[223] W. Markesbery. The role of oxidative stress in Alzheimer disease. , 1999, Archives of neurology.
[224] B. Rosen,et al. Involvement of Free Radicals in Excitotoxicity In Vivo , 1995, Journal of neurochemistry.
[225] P. S. Shelton,et al. Vitamin E in the Treatment of Tardive Dyskinesia , 1999, The Annals of pharmacotherapy.
[226] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[227] E. Melamed,et al. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier , 2001, Neuropharmacology.
[228] D. Borchelt,et al. Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease , 1996, Neurology.
[229] Lin Chen,et al. Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. , 1994, The International journal of neuroscience.
[230] W. Herrmann,et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. , 1997, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[231] A. Rao,et al. Effect of diet and smoking on serum lycopene and lipid peroxidation , 1998 .
[232] P. Hollman,et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.
[233] J. Goodwin,et al. Association between nutritional status and cognitive functioning in a healthy elderly population. , 1983, JAMA.
[234] Y. Christen,et al. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. , 1999, Free radical biology & medicine.
[235] C. Behl,et al. Antioxidants as treatment for neurodegenerative disorders , 2002, Expert opinion on investigational drugs.
[236] A. Boveris,et al. Myocardial damage induced by doxorubicins: hydroperoxide-initiated chemiluminescence and morphology. , 1990, Free radical biology & medicine.
[237] G. Cole,et al. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.
[238] G. Cohen,et al. Deprenyl suppresses the oxidant stress associated with increased dopamine turnover , 1989, Annals of neurology.
[239] C. Schwarz,et al. Wild-Type and Mutant Huntingtins Function in Vesicle Trafficking in the Secretory and Endocytic Pathways , 1998, Experimental Neurology.
[240] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[241] M. Danilenko,et al. Molecular mechanisms for the anticancer activity of the carotenoid lycopene , 2000 .
[242] S Moncada,et al. Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. , 1989, Biochemical pharmacology.
[243] M. Beal,et al. Bioenergetics in Huntington's Disease , 1999, Annals of the New York Academy of Sciences.
[244] A. Hofman,et al. Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. , 1996, American journal of epidemiology.
[245] M. Grundman. Vitamin E and Alzheimer disease: the basis for additional clinical trials. , 2000, The American journal of clinical nutrition.
[246] R. Rouseff,et al. Flavanone absorption after naringin, hesperidin, and citrus administration , 1996, Clinical pharmacology and therapeutics.
[247] J. Tainer,et al. Two novel SOD1 mutations in patients with familial amyotrophic lateral sclerosis. , 1995, Human molecular genetics.